Approval · Notice of Compliance 36656 · 2025
BOSULIF: Notice of Compliance 36656
Issued December 31, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36656
- Date
- December 31, 2025
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product Monograph reformatted to the Master Template / Removal of strength: [400 mg]
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BOSULIF | Not yet assigned | — |
Medicinal ingredients
- BOSUTINIB MONOHYDRATE 100 MG per TAB
- BOSUTINIB MONOHYDRATE 500 MG per TAB